Opendata, web and dolomites

INTERLACE

Interacting Decentralized Transactional and Ledger Architecture for Mutual Credit

Total Cost €

0

EC-Contrib. €

0

Partnership

0

Views

0

 INTERLACE project word cloud

Explore the words cloud of the INTERLACE project. It provides you a very rough idea of what is the project "INTERLACE" about.

notaries    tree    otx    framework    mutual    generate    electronic    blockchain    started    local    intermediate    interaction    output    demonstrator    sardex    trustful    node    centralized    commerciale    capacity    protocol    machines    source    binary    fp7    persistence    uniquely    interlace    hash    credit    credito    bit    notary    circuits    transactional    circuito    b2b    central    space    architecture    abstract    monetizing    taxable    transactions    socio    layer    continuity    multiple    actors    transaction    fintech    transformative    deeply    decentralized    identity    sparse    successfully    distributed    computational    architectures    companies    solution    workprogramme    create    fet    innovative    validate    successful    circular    spare    first    cultural    form    nodes    sardinia    auditor    economy    economic    server    2009    fashion    executed    achieves    private    smes    positioned    ledger    solidarity    scalability    trade    zero    participating    biomics    trust    basis    platform    160    pool    di    mathematical    digital    coreasim    add    island    integrate    stored   

Project "INTERLACE" data sheet

The following table provides information about the project.

Coordinator
SARDEX SPA 

Organization address
address: VIA SERRA 44
city: SERRAMANNA
postcode: 9038
website: n.a.

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.

 Coordinator Country Italy [IT]
 Project website https://interlaceproject.eu
 Total cost 99˙978 €
 EC max contribution 99˙978 € (100%)
 Programme 1. H2020-EU.1.2.1. (FET Open)
 Code Call H2020-FETOPEN-4-2016-2017
 Funding Scheme CSA
 Starting year 2017
 Duration (year-month-day) from 2017-05-01   to  2018-10-31

 Partnership

Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    SARDEX SPA IT (SERRAMANNA) coordinator 23˙000.00
2    FACHOCHSCHULE SALZBURG GMBH AT (PUCH BEI HALLEIN) participant 46˙822.00
3    UNIVERSITAT PASSAU DE (PASSAU) participant 18˙800.00
4    THE UNIVERSITY OF HERTFORDSHIRE HIGHER EDUCATION CORPORATION UK (HATFIELD) participant 11˙356.00

Map

 Project objective

The objective of INTERLACE is to use the Abstract State Interaction Machines framework (CoreASIM) open source output of the FP7 FET project BIOMICS to develop a decentralized transactional and ledger architecture demonstrator for B2B mutual credit. INTERLACE will add to the work already started by its coordinator, Sardex s.r.l., to develop this architecture. SARDEX will use the Open Transaction protocol (OTX) as an intermediate solution between fully centralized and distributed architectures. OTX involves a pool of Auditor nodes to validate the transactions executed by each Notary node. In INTERLACE there will be only one central Notary, as a first step from the current centralized server towards a more distributed architecture. The persistence layer will be implemented as a private blockchain stored on the central server to create a sparse 160-bit address space implemented as a binary hash tree. This approach achieves continuity with the existing solution while also enabling scalability to multiple circuits (multiple Notaries) under the same mathematical and computational framework. SARDEX has been operating successfully an electronic, B2B, zero-interest mutual credit system on the island of Sardinia since 2009. The Sardex system (also known as Circuito di Credito Commerciale) enables local economic actors (SMEs in particular) to trade with each other in a trustful and circular fashion with a unique digital trade credit unit. It does this by monetizing the spare capacity of the local economy in the form of mutual, and taxable, credit between participating companies, at zero interest, on a strong basis of trust, solidarity, and local cultural identity. Therefore, INTERLACE will address very effectively the Workprogramme objective to generate socio-economic impact from EU-funded research. INTERLACE is uniquely positioned to integrate the very advanced results of BIOMICS directly in a deeply innovative, transformative, and successful fintech platform for B2B trade.

 Deliverables

List of deliverables.
Final Architecture Documents, reports 2019-05-15 17:08:20
Project Website Websites, patent fillings, videos etc. 2019-05-15 17:08:20
Iterative Architecture Refinement Documents, reports 2019-05-15 17:08:20
Requirements and Architecture Definition Documents, reports 2019-05-15 17:08:20
Final Demonstrator Implementation Demonstrators, pilots, prototypes 2019-05-15 17:08:20
First Demonstrator Implementation Demonstrators, pilots, prototypes 2019-05-15 17:08:20

Take a look to the deliverables list in detail:  detailed list of INTERLACE deliverables.

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "INTERLACE" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "INTERLACE" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.1.2.1.)

PANACHE (2020)

Production of next generation modulators of pannexins and connexins as novel therapeutics in the treatment of inflammatory cardiovascular, hepatic and joint diseases.

Read More  

NOVIRUSES2BRAIN (2019)

''One size fits all'' unique drug to eradicate multiple viral species simultaneously from the central nervous system of co-infected individuals

Read More  

BRIEFING (2018)

Bridging the FET Innovation Gap

Read More